Package: adaptIVPT
Type: Package
Title: Adaptive Bioequivalence Design for In-Vitro Permeation Tests
Version: 1.1.0
Date: 2024-01-14
Authors@R: c(
        person("Daeyoung", "Lim", email = "Daeyoung.Lim@fda.hhs.gov",
        role = c("aut", "cre")),
        person("Elena", "Rantou", email = "Elena.Rantou@fda.hhs.gov", role = "ctb"),
        person("Jessica", "Kim", email = "Jessica.Kim@fda.hhs.gov", role = "ctb"),
        person("Sungwoo", "Choi", email = "Sungwoo.Choi@fda.hhs.gov", role = "ctb"),
        person("Nam Hee", "Choi", email = "NamHee.Choi@fda.hhs.gov", role = "ctb"),
        person("Stella", "Grosser", email = "Stella.Grosser@fda.hhs.gov", role = "ctb"))
Maintainer: Daeyoung Lim <Daeyoung.Lim@fda.hhs.gov>
Description: Contains functions carrying out adaptive procedures using mixed scaling approach to establish bioequivalence for in-vitro permeation test (IVPT) data. Currently, the package provides procedures based on parallel replicate design and balanced data, according to the U.S. Food and Drug Administration's "Draft Guidance on Acyclovir" <https://www.accessdata.fda.gov/drugsatfda_docs/psg/Acyclovir_topical%20cream_RLD%2021478_RV12-16.pdf>. Potvin et al. (2008) <doi:10.1002/pst.294> provides the basis for our adaptive design (see Method B). For a comprehensive overview of the method, refer to Lim et al. (2023) <doi:10.1002/pst.2333>. This package reflects the views of the authors and should not be construed to represent the views or policies of the U.S. Food and Drug Administration.
License: GPL (>= 3)
Encoding: UTF-8
LazyLoad: yes
RoxygenNote: 7.2.1
NeedsCompilation: yes
Imports: Rcpp, rgl
Depends: R (>= 3.4)
LinkingTo: Rcpp, RcppArmadillo, RcppProgress
Suggests: knitr, rmarkdown
Packaged: 2024-01-23 18:05:44 UTC; daeyounglim
Author: Daeyoung Lim [aut, cre],
  Elena Rantou [ctb],
  Jessica Kim [ctb],
  Sungwoo Choi [ctb],
  Nam Hee Choi [ctb],
  Stella Grosser [ctb]
Repository: CRAN
Date/Publication: 2024-01-26 20:00:03 UTC
